PA
YARW

Perceptive Advisors’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Perceptive Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,420
Closed -$2.22M – 152
2021
Q4 		$2.22M Sell
2,420
-169
-7% -$181K 0.03% 133
2021
Q3 		$3.24M Sell
2,589
-3,827
-60% -$7.42M 0.05% 126
2021
Q2 		$20.3M Sell
6,416
-1,111
-15% -$4.4M 0.26% 82
2021
Q1 		$46.4M Buy
7,527
+1,172
+18% +$8.5M 0.59% 46
2020
Q4 		$36.1M Hold
6,355
– – 0.39% 57
2020
Q3 		$38M Hold
6,355
– – 0.55% 47
2020
Q2 		$39.6M Buy
6,355
+4,511
+245% +$30.5M 0.64% 38
2020
Q1 		$17.5M Buy
+1,844
New +$28.9M 0.45% 43
2018
Q3 		– Sell
-345
Closed -$10.1M – 135
2018
Q2 		$10.1M Sell
345
-99
-22% -$3.85M 0.26% 59
2018
Q1 		$60.1M Buy
+444
New +$54M 1.68% 17

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Perceptive Advisors's YARW Position: Q1 2022 in Review

Perceptive Advisors sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2022, closing a stake of 2,420 shares — an estimated $2.22M sold.

Perceptive Advisors first reported a position in YARW in Q1 2018 and held it in 10 quarters. The position peaked at $60.1M in Q1 2018. 41 funds tracked by Wall St. Rank hold YARW as of Q1 2022.

  • Perceptive Advisors reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Perceptive Advisors sold 2,420 Yarrow Bioscience, Inc. Common Stock shares in Q1 2022, an estimated $2.22M.
  • Perceptive Advisors first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and held it in 10 quarters.
  • Perceptive Advisors's Yarrow Bioscience, Inc. Common Stock position peaked at $60.1M in Q1 2018.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2022.

Based on Perceptive Advisors's 13F filing for Q1 2022, filed 16 May 2022.